Yan Helen H N, Chan April S, Lai Frank Pui-Ling, Leung Suet Yi
Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China.
Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China.
Cell Stem Cell. 2023 Jul 6;30(7):917-937. doi: 10.1016/j.stem.2023.05.012. Epub 2023 Jun 13.
Organoids derived from adult stem cells (ASCs) and pluripotent stem cells (PSCs) are important preclinical models for studying cancer and developing therapies. Here, we review primary tissue-derived and PSC-derived cancer organoid models and detail how they have the potential to inform personalized medical approaches in different organ contexts and contribute to the understanding of early carcinogenic steps, cancer genomes, and biology. We also compare the differences between ASC- and PSC-based cancer organoid systems, discuss their limitations, and highlight recent improvements to organoid culture approaches that have helped to make them an even better representation of human tumors.
源自成体干细胞(ASC)和多能干细胞(PSC)的类器官是研究癌症和开发治疗方法的重要临床前模型。在此,我们综述了源自原发性组织和PSC的癌症类器官模型,并详细阐述了它们如何有潜力为不同器官背景下的个性化医疗方法提供信息,并有助于理解早期致癌步骤、癌症基因组和生物学。我们还比较了基于ASC和PSC的癌症类器官系统之间的差异,讨论了它们的局限性,并强调了类器官培养方法的最新改进,这些改进有助于使它们更好地代表人类肿瘤。